Introduction
Recombinant Human PADI4 Protein, also known as Peptidyl Arginine Deiminase 4, is a human enzyme that plays a crucial role in the post-translational modification of proteins. This protein is encoded by the PADI4 gene and is involved in the conversion of arginine residues to citrulline, a process known as citrullination. Recombinant Human PADI4 Protein is widely used in research and diagnostic applications due to its unique structure and activity.
Structure of Recombinant Human PADI4 Protein
Recombinant Human PADI4 Protein is a 74 kDa protein consisting of 663 amino acids. It belongs to the peptidyl arginine deiminase family and contains a conserved catalytic domain with a calcium-binding site. The protein also has a nuclear localization signal and is predominantly found in the nucleus of cells.
The crystal structure of Recombinant Human PADI4 Protein has been determined, revealing a globular shape with a central catalytic domain surrounded by several loops and helices. The active site of the protein is located in a deep pocket, where the catalytic calcium ion is coordinated by three aspartic acid residues. This unique structure allows the protein to specifically bind to and modify arginine residues in target proteins.
Activity of Recombinant Human PADI4 Protein
The main function of Recombinant Human PADI4 Protein is to catalyze the conversion of arginine residues to citrulline in target proteins. This process, known as citrullination, is a post-translational modification that plays a crucial role in various biological processes such as gene regulation, protein-protein interactions, and immune responses.
Recombinant Human PADI4 Protein has a high specificity for arginine residues and can modify both free and protein-bound arginine. The protein is also able to citrullinate multiple arginine residues in a single target protein, leading to the formation of multiple citrulline residues. This activity is essential for the proper functioning of many proteins that undergo citrullination.
Applications of Recombinant Human PADI4 Protein
Recombinant Human PADI4 Protein has a wide range of applications in both research and diagnostics due to its unique structure and activity. Some of the key applications of this protein include:
1. Research
Recombinant Human PADI4 Protein is extensively used in research to study the role of citrullination in various biological processes. It is also used to identify and characterize citrullinated proteins and their functions. The protein can be used to study the effects of citrullination on protein structure, function, and interactions, providing insights into the mechanisms of various diseases such as rheumatoid arthritis and cancer.
2. Diagnostics
Recombinant Human PADI4 Protein is also used in diagnostic assays to detect the presence of citrullinated proteins in patient samples. This is particularly useful in the diagnosis of autoimmune diseases such as rheumatoid arthritis, where citrullinated proteins are known to be involved. The protein can also be used to develop diagnostic tests for other diseases that involve citrullination, providing a more accurate and specific diagnosis.
3. Drug Development
The unique activity of Recombinant Human PADI4 Protein makes it an attractive target for drug development. Inhibitors of this protein could potentially be used to treat diseases that involve excessive citrullination, such as rheumatoid arthritis. The protein can also be used in high-throughput screening assays to identify potential inhibitors, providing a valuable tool for drug discovery.
Conclusion
In summary, Recombinant Human PADI4 Protein is a crucial enzyme that plays a key role in the post-translational modification of
There are no reviews yet.